This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005 Jan:46 Suppl 1:1S-3S.

A pragmatic perspective on molecular targeted radionuclide therapy

Steven M Larson¹, Eric P Krenning

Affiliations

PMID: 15653645

Free article

A pragmatic perspective on molecular targeted radionuclide therapy

Steven M Larson et al. J Nucl Med. 2005 Jan.

Free article

. 2005 Jan:46 Suppl 1:1S-3S.

Authors

Steven M Larson¹, Eric P Krenning

Affiliation

¹ Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. larsons@mskcc.org

PMID: 15653645

No abstract available

PubMed Disclaimer

Comment in

JNM supplement on molecular radiotherapy.
Wong CO, Pandit-Taskar N, Larson SM. Wong CO, et al. J Nucl Med. 2005 Oct;46(10):1765-6; author reply 1766. J Nucl Med. 2005. PMID: 16204728 No abstract available.

Similar articles

JNM supplement on molecular radiotherapy.
Wong CO, Pandit-Taskar N, Larson SM. Wong CO, et al. J Nucl Med. 2005 Oct;46(10):1765-6; author reply 1766. J Nucl Med. 2005. PMID: 16204728 No abstract available.
Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM, Goldenberg DM. Sharkey RM, et al. J Nucl Med. 2005 Jan;46 Suppl 1:115S-27S. J Nucl Med. 2005. PMID: 15653660 Review.
Current status of therapy of solid tumors.
Jhanwar YS, Divgi C. Jhanwar YS, et al. J Nucl Med. 2005 Jan;46 Suppl 1:141S-50S. J Nucl Med. 2005. PMID: 15653662
The promise of targeted {alpha}-particle therapy.
Mulford DA, Scheinberg DA, Jurcic JG. Mulford DA, et al. J Nucl Med. 2005 Jan;46 Suppl 1:199S-204S. J Nucl Med. 2005. PMID: 15653670 Review.
Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
Reilly RM. Reilly RM. J Nucl Med. 2006 Feb;47(2):196-9. J Nucl Med. 2006. PMID: 16455623 Review. No abstract available.

See all similar articles

Cited by

Auger radiation targeted into DNA: a therapy perspective.
Buchegger F, Perillo-Adamer F, Dupertuis YM, Delaloye AB. Buchegger F, et al. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1352-63. doi: 10.1007/s00259-006-0187-2. Epub 2006 Aug 8. Eur J Nucl Med Mol Imaging. 2006. PMID: 16896663 Review.
Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene.
Zhong X, Shi C, Gong J, Guo B, Li M, Xu H. Zhong X, et al. PLoS One. 2015 Jan 23;10(1):e0117053. doi: 10.1371/journal.pone.0117053. eCollection 2015. PLoS One. 2015. PMID: 25615643 Free PMC article.
A proposed methodology to select radioisotopes for use in radionuclide therapy.
Cuaron JJ, Hirsch JA, Medich DC, Rosenstein BS, Martel CB, Hirsch AE. Cuaron JJ, et al. AJNR Am J Neuroradiol. 2009 Nov;30(10):1824-9. doi: 10.3174/ajnr.A1773. Epub 2009 Aug 6. AJNR Am J Neuroradiol. 2009. PMID: 19661172 Free PMC article.
Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
Carlsson J, Eriksson V, Stenerlöw B, Lundqvist H. Carlsson J, et al. Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1185-95. doi: 10.1007/s00259-006-0109-3. Epub 2006 May 23. Eur J Nucl Med Mol Imaging. 2006. PMID: 16718515 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire